Role of epidural fat in the local milieu: what we know and what we don't

被引:2
作者
Liu, Zhiming [1 ]
Wang, Yida [1 ]
Ma, Xuexiao [1 ]
Zhang, Lu [2 ]
Wang, Chao [1 ]
机构
[1] Qingdao Univ, Dept Spine Surg, Affiliated Hosp, Qingdao, Peoples R China
[2] Qingdao Univ, Dept Med Res Ctr, Affiliated Hosp, Qingdao, Peoples R China
基金
中国国家自然科学基金;
关键词
Epidural fat; spinal epidural lipomatosis; inflammation; obesity; spinal deformity; hypertrophy; HUMAN-IMMUNODEFICIENCY-VIRUS; FAILED-BACK SYNDROME; LUMBAR DISC SURGERY; STEM-CELLS; ADIPOSE-TISSUE; LIPOMATOSIS; PATIENT; PREVENTION; OBESITY; LAMINECTOMY;
D O I
10.1080/03008207.2024.2329871
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PurposeTraditionally, the epidural fat (EF) is known as a physical buffer for the dural sac against the force and a lubricant facilitating the relative motion of the latter on the osseous spine. Along with the development of the studies on EF, controversies still exist on vital questions, such as the underlying mechanism of the spinal epidural lipomatosis. Meanwhile, the scattered and fragmented researches hinder the global insight into the seemingly dispensable tissue.MethodsHerein, we reviewed literature on the EF and its derivatives to elucidate the dynamic change and complex function of EF in the local milieu, especially at the pathophysiological conditions. We start with an introduction to EF and the current pathogenic landscape, emphasizing the interlink between the EF and adjacent structures. We generally categorize the major pathological changes of the EF into hypertrophy, atrophy, and inflammation.Results and conclusionsIt is acknowledged that not only the EF (or its cellular components) may be influenced by various endogenic/exogenic and focal/systematic stimuli, but the adjacent structures can also in turn be affected by the EF, which may be a hidden pathogenic clue for specific spinal disease. Meanwhile, the unrevealed sections, which are also the directions the future research, are proposed according to the objective result and rational inference. Further effort should be taken to reveal the underlying mechanism and develop novel therapeutic pathways for the relevant diseases.
引用
收藏
页码:102 / 116
页数:15
相关论文
共 50 条
  • [1] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [2] International Trade and Investment and Food Systems: What We Know, What We Don't Know, and What We Don't Know We Don't Know
    Schram, Ashley
    Townsend, Belinda
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2021, 10 (12) : 886 - 895
  • [3] Neprilysin Inhibition: What We Know and What We Don't Know
    Buttrick, Peter
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (04) : 276 - 277
  • [4] Overcoming Inequities in Obesity: What Don't We Know That We Need to Know?
    Kumanyika, Shiriki
    HEALTH EDUCATION & BEHAVIOR, 2019, 46 (05) : 721 - 727
  • [5] Human Extraintestinal Sarcocystosis: What We Know, and What We don't Know
    Harris, V. C.
    van Vugt, M.
    Aronica, E.
    de Bree, G. J.
    Stijnis, C.
    Goorhuis, A.
    Grobusch, M. P.
    CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (08)
  • [6] Illicit drugs in Central Asia: What we know, what we don't know, and what we need to know
    Latypov, Alisher
    Grund, Jean-Paul
    El-Bassel, Nabila
    Platt, Lucy
    Stoever, Heino
    Strathdee, Steffanie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (06) : 1155 - 1162
  • [7] Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don't
    Novikoff, Aaron
    Mueller, Timo D.
    PHYSIOLOGY, 2024, 39 (03) : 142 - 156
  • [8] Lipedema: What we don't know
    van la Parra, R. F. D.
    Deconinck, C.
    Pirson, G.
    Servaes, M.
    Fosseprez, Ph.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2023, 84 : 302 - 312
  • [9] Chlamydia pneumoniae and atherosclerosis -: what we know and what we don't
    Ngeh, J
    Anand, V
    Gupta, S
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (01) : 2 - 13
  • [10] Low Carbohydrate and Low-Fat Diets: What We Don't Know and Why We Should Know It
    Seid, Heather
    Rosenbaum, Michael
    NUTRIENTS, 2019, 11 (11)